Efficacy of lanadelumab in patients with HAE is independent of body mass index: Findings from the HELP study

被引：0
|
作者：
Zanichelli, A. [1 ]
Hebert, J. [2 ]
Soteres, D. [3 ]
Hao, J. [4 ]
Lu, P. [4 ]
Busse, P. [5 ]
机构：
[1] Univ Milan, Dept Biomed & Clin Sci, ASST Fatebenefratelli Sacco, Luigi Sacco, Milan, Italy
[2] Ctr Rech Appl Allergie Quebec, Quebec City, PQ, Canada
[3] Asthma & Allergy Associates PC, Colorado Springs, CO USA
[4] Shire, Lexington, MA USA
[5] Icahn Sch Med Mt Sinai, Div Clin Immunol & Allergy, Dept Med, New York, NY 10029 USA
来源：
ALLERGY | 2018年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
1429
引用
收藏
页码：722 / 723
页数：2
相关论文
共 50 条
  • [31] Real-world effectiveness of lanadelumab in European patients with HAE type I/II: Results from the retrospective integrated study
    Magerl, M.
    Bouillet, L.
    Saguer, I. Martinez
    Gavini, F.
    Andresen, I.
    Bent-Ennakhil, N.
    Sayegh, L.
    ALLERGY, 2023, 78 : 146 - 146
  • [32] Pretreatment body mass index as an independent prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy: Findings from a randomised trial
    Huang, Pei-Yu
    Wang, Cheng-Tao
    Cao, Ka-Jia
    Guo, Xiang
    Guo, Ling
    Mo, Hao-Yuan
    Wen, Bi-Xiu
    Wu, Yi-Shan
    Mai, Hai-Qiang
    Hong, Ming-Huang
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (08) : 1923 - 1931
  • [33] Can body mass index help predict outcome in patients with bipolar disorder?
    Calkin, Cynthia
    van de Velde, Caroline
    Ruzickova, Martina
    Slaney, Claire
    Garnham, Julie
    Hajek, Tomas
    O'Donovan, Claire
    Alda, Martin
    BIPOLAR DISORDERS, 2009, 11 (06) : 650 - 656
  • [34] LONG-TERM EFFICACY OF LANADELUMAB: INTERIM RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY
    Riedl, M.
    Cicardi, M.
    Hao, J.
    Lu, P.
    Li, H.
    Manning, M.
    Bernstein, J.
    Busse, P.
    Tachdjian, R.
    Gower, R.
    Wedner, H.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S30 - S31
  • [35] LANADELUMAB SAFETY AND IMMUNOGENICITY: RESULTS FROM THE PHASE 3 HELP STUDY
    Johnston, D.
    Banerji, A.
    Riedl, M.
    Zuraw, B.
    Lumry, W.
    Bernstein, J.
    Li, H.
    Lu, P.
    Hao, J.
    Gower, R.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S36 - S36
  • [36] Body mass index and the diagnosis of endometriosis: Findings from a national data linkage cohort study
    Rowlands, Ingrid J.
    Hockey, Richard
    Abbott, Jason A.
    Montgomery, Grant W.
    Mishra, Gita D.
    OBESITY RESEARCH & CLINICAL PRACTICE, 2022, 16 (03) : 235 - 241
  • [37] Body Mass Index and Mortality among Japanese Older Adults: Findings from the JACC Study
    Tamakoshi, Akiko
    Yatsuya, Hiroshi
    Lin, Yingsong
    Tamakoshi, Koji
    Kondo, Takaaki
    Suzuki, Sadao
    Yagyu, Kiyoko
    Kikuchi, Shogo
    OBESITY, 2009, 17 : S156 - S157
  • [38] Insulin and leptin are related independent from body mass index.
    Stolk, RP
    Janssen, JAM
    Pols, HAP
    Inglaro, P
    Blum, WF
    Attanasio, AMF
    Grobbee, DE
    Lamberts, SWJ
    DIABETOLOGIA, 1997, 40 : 1031 - 1031
  • [39] THE ECONOMIC BURDEN OF HAE: FINDINGS FROM THE HAE BURDEN OF ILLNESS STUDY IN EUROPE (HAE-BOIS-EUROPE)
    Aygoeren-Puersuen, E.
    Bygum, A.
    Caballero, T.
    Beusterien, K.
    Hautamaki, E.
    Musingarimi, P.
    Wait, S.
    Boysen, H.
    VALUE IN HEALTH, 2012, 15 (07) : A565 - A566
  • [40] Lanadelumab treatment patterns among patients with HAE-C1-INH: Interim analysis of the ENABLE study
    Recke, A.
    Spadaro, G.
    Greve, J.
    Zanichelli, A.
    Hartmann, K.
    Agmon-Levin, N.
    Lleonart, R.
    Andriotti, T.
    Fei, K.
    Yegin, A.
    Aygoren-Pursun, E.
    ALLERGY, 2023, 78 : 12 - 13
12345